Latest Regulatory Approvals News

Empire Energy has successfully raised $28 million through a placement and launched a $3 million Share Purchase Plan to fund critical development of its Carpentaria-5H well in the Beetaloo Sub-basin.

ECS Botanics is on track for a record-breaking FY25 harvest with a 50% production increase and new premium product launches, signaling strong growth and a positive cash flow outlook.

Midas Minerals has announced a transformative acquisition of the Otavi Copper-Gold-Silver Project in Namibia, unlocking significant exploration potential with plans to commence drilling later this year.

Metgasco Ltd has announced a non-renounceable entitlement offer to raise approximately $0.75 million at a discounted price of 0.2 cents per share, aiming to fund production uplift programs and working capital. The offer is partially underwritten and includes a Top-Up Facility for eligible shareholders.

Manuka Resources’ Taranaki VTM Project has cleared a key regulatory hurdle, moving forward in New Zealand’s Fast-track Approvals Process with promising economic and environmental prospects.

Mayne Pharma Group has proposed a $7.40 per share acquisition by Cosette Pharmaceuticals, with unanimous board support and a fair and reasonable opinion from an independent expert. Shareholders will vote on the scheme on June 18, 2025.

HITIQ Limited has announced a non-renounceable entitlement offer to raise up to $2.92 million, supported by partial underwriting from GBA Capital and accompanied by new options issuance. The capital raise aims to fund expansion, product development, and operational growth.

Embark Early Education announces a fully franked interim dividend and the conditional acquisition of two Queensland childcare centres, boosting its portfolio to 40 centres.

Mesoblast has been granted a seven-year orphan-drug exclusivity by the FDA for its cell therapy Ryoncil, reinforcing its market position in treating steroid-refractory acute graft versus host disease in children.

Southern Cross Gold has successfully closed the second tranche of its C$143 million private placement, securing nearly C$30 million to fund critical milestones at its Sunday Creek Gold-Antimony Project in Australia.

Peak Rare Earths is poised for acquisition by Shenghe Resources in a deal valuing the company at A$150.5 million, supported by a A$7.5 million entitlement offer to fund ongoing development and transaction costs.

Peak Rare Earths Limited has agreed to be acquired by Ganzhou Chenguang Rare Earths New Material Co., Ltd., a subsidiary of Shenghe Resources, in a deal valuing Peak at A$150.5 million plus proceeds from a proposed entitlement offer. The transaction offers Peak shareholders a significant premium and aims to accelerate development of the Ngualla Rare Earth Project.